Polymer conjugates of the highly potent cytostatic drug 2-pyrrolinodoxorubicin

Autor: Studenovsky, M., Ulbrich, K., Ibrahimova, M., Rihova, B.

Publikováno v: In European Journal of Pharmaceutical Sciences 2011 42(1):156-163

Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: In vitro effect of extra drug-free GlyPheLeuGly sequences

Autor: Říhová, B., Strohalm, J., Hovorka, O., Šubr, V., Etrych, T., Chytil, P., Pola, R., Plocová, D., Bouček, J., Ulbrich, K.

Publikováno v: In Journal of Controlled Release 2008 127(2):110-120

Simultaneous Delivery of Doxorubicin and Protease Inhibitor Derivative to Solid Tumors via Star-Shaped Polymer Nanomedicines Overcomes P-gp- and STAT3-Mediated Chemoresistance.

Autor: Kostka L; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16206 Prague, Czech Republic., Sivák L; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic., Šubr V; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16206 Prague, Czech Republic., Kovářová J; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic., Šírová M; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic., Říhová B; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic., Sedlacek R; Czech Center of Phenogenomics, Institute of Molecular Genetics, Czech Academy of Sciences, Průmyslová 595, 25250 Vestec, Czech Republic., Etrych T; Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 16206 Prague, Czech Republic., Kovář M; Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, 14220 Prague, Czech Republic.

Publikováno v: Biomacromolecules [Biomacromolecules] 2022 Jun 13; Vol. 23 (6), pp. 2522-2535. Date of Electronic Publication: 2022 May 18.

Differences in the intracellular fate of free and polymer-bound doxorubicin

Autor: Hovorka, Ondřej, Št’astný, M, Etrych, T, Šubr, V, Strohalm, J, Ulbrich, K, Říhová, B ^∗

Publikováno v: In Journal of Controlled Release 23 April 2002 80(1-3):101-117

Acquired and specific immunological mechanisms co-responsible for efficacy of polymer-bound drugs

Autor: Řı́hová, B ^∗, Strohalm, J, Kubáčková, K, Jelı́nková, M, Hovorka, O, Kovář, M, Plocová, D, Šı́rová, M, Št’astný, M, Rozprimová, L, Ulbrich, K

Publikováno v: In Journal of Controlled Release 2002 78(1):97-114